Myocardial infarction or myocarditis? A case report and review of a myocardial adverse event associated with mRNA vaccine

A 23-year-old man started with chest pain 8 h after his first Pfizer-BioNTech COVID-19 vaccination. ECG evaluation showed sinus tachycardia with ST-segment elevation in D1, AVL, V5, and V6, the findings compatible with acute subepicardial myocardial damage. However, cardiac MRI documented myocardial...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in medicine 2023-02, Vol.10, p.1071239
Main Authors: Badaró, Roberto, Novaes, Gustavo, Andrade, Ana Cristina, de Araujo Neto, Cesar Augusto, Machado, Bruna Aparecida, Barbosa, Josiane Dantas Viana, Soares, Milena Botelho Pereira
Format: Article
Language:English
Subjects:
adverse event
cardiac disease
cardiotoxicity
COVID-19
Medicine
mRNA vaccine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 23-year-old man started with chest pain 8 h after his first Pfizer-BioNTech COVID-19 vaccination. ECG evaluation showed sinus tachycardia with ST-segment elevation in D1, AVL, V5, and V6, the findings compatible with acute subepicardial myocardial damage. However, cardiac MRI documented myocardial fibrosis, with cardiac late enhancement non-ischemic pattern with diffuse edema. He had no other symptoms to suggest another etiology than the vaccination. The patient was hospitalized and received corticosteroid (prednisolone) daily. Then, 2 weeks after hospitalization, all laboratory parameters and ECG were normal and the patient was discharged from the hospital. The patient had a history of Wolf-Parkinson White that was corrected with ablation when he was 11 years old. This report calls attention to myocardial adverse reaction risk for mRNA COVID-19 vaccines for people with a previous cardiac disease history.
ISSN:2296-858X
2296-858X
DOI:10.3389/fmed.2023.1071239